Skip to main content
Log in

Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among iranian women: An interphase FISH analysis

  • Article
  • Published:
Pathology & Oncology Research

Abstract

Breast cancer is amongst the leading causes of death in women worldwide and the most common cancer amongst Iranian women. Unfortunately, the current clinical and histological criteria can only help 60 percent of women with breast cancer in diagnosis and long-term treatment. Therefore, genetic markers both at single gene and chromosomal level can play an important role in improving the diagnosis and prognosis of breast cancer patients. The aim of this retrospective study was to investigate the role of chromosome 1 and 8 copy number assessed by interphase fluorescence in situ hybridization (FISH), as prognostic parameters in 50 Iranian women, aged 35 to 64 years, with sporadic invasive ductal breast carcinoma. Chromosome 1 and 8 copy numbers were evaluated in relation to established clinicopathological parameters, the immunohistochemical markers ER, PR, P53 and cathepsin D, DNA index by flow cytometry, age and survival status of the patients. FISH using centromeric probes for chromosomes 1 and 8 was applied to interphase cell suspensions prepared from archived, Carnoyfixed tumor cells and selected paraffin-embedded tumor sections. Aneusomy for chromosomes 1 and 8 was present in all 50 patients to different levels. The total abnormality rate for chromosome 1 was 33.92 percent (4.24 percent monosomy and 29.68 percent polysomy), whereas for chromosome 8 this rate was 28.30 percent (6.48 percent monosomy and 21.82 percent polysomy). Statistically significant association (p<0.05) was demonstrated between monosomy 1 and patients’ age below 50 years, and between monosomy 1 and poor survival, respectively. Disomy 8 was significantly associated with P53 expression. A borderline significant correlation was demonstrated between polysomy 8 and diploid DNA content, as well as between disomy 1 and disease-free status of the patients. Chromosome 1 and 8 copy numbers may be considered as useful prognostic markers in invasive ductal carcinoma of the breast.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adeyinka A, Mertens F, Idvall I, et al: Multiple polysomies in breast carcinoma: preferential gain of chromosomes 1, 5, 6, 7, 12, 16, 17, 18, and 19. Cancer Genet Cytogenet 111: 144–148, 1999.

    Article  PubMed  CAS  Google Scholar 

  2. Atri M, Jafarimojarrad E, Javidroozi M, Mehdipour P: Lack of association between early onset of breast cancer and numbers of affected relatives in an Iranian population. Fam Cancer 2: 117–118, 2003.

    Article  PubMed  CAS  Google Scholar 

  3. Bertucci F, Nasser V, Granjeaud S, Houlgatte R: Gene expression profiles of poor prognosis primary breast cancer correlate with survival. Hum Mol Genet 11: 863–872, 2002.

    Article  PubMed  CAS  Google Scholar 

  4. Botti C, Pescatore B, Mottolese M., et al: Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue with interphase cytogenetic study. J Am Coll Surg 190: 530–539, 2000.

    Article  PubMed  CAS  Google Scholar 

  5. Dies PJV, Baak JPA, Cok PM, et al: Reproducibility of mitosis counting in 2,469 breast cancer specimens. Hum Pathol 23: 603–607, 1992.

    Article  Google Scholar 

  6. Dominguez D, Silva J, Silve JM, et al: Clinicopathological characteristics of breast carcinoma with allelic loss in the p73 region. Breast Cancer Res Treat 63: 17–22, 2000.

    Article  PubMed  CAS  Google Scholar 

  7. Elston CW: Grading of invasive carcinoma of the breast. In: Diagnostic Histopathology of the Breast. (Eds: Page DL, Anderson TJ), Churchill-Livingstone, Edinburgh, 1987, pp 300–311.

    Google Scholar 

  8. Fehm T, Morrison L, Saboorian H, et al: Patterns of aneusomy for three chromosomes in individual cells from breast cancer tumors. Breast Cancer Res Treat 75: 227–239, 2002.

    Article  PubMed  CAS  Google Scholar 

  9. Ferti AD, Stamouli MJ, Panard AD, et al: Molecular cytogenetic analysis of breast cancer: a combined multicolour fluorescence in situ hybridization and G-banding study of uncultured tumor cells. Cancer Genet Cytogenet 149: 28–37, 2004.

    Article  PubMed  Google Scholar 

  10. Fitzgibbons PL, Page DL, Weaver D: Prognostic factors in breast cancer, College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 966–978, 2000.

    PubMed  CAS  Google Scholar 

  11. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ: Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev 5: 24–27, 2004.

    PubMed  Google Scholar 

  12. Harrison MM, Magee HM, O’loughlin JF: Comparison of chromosome 1 aneusomy detected by interphase cytogenetics and DNA ploidy in carcinoma of the breast. Histopathology 3: 221–226, 1997.

    Article  Google Scholar 

  13. Haskell CM: Cancer Treatment, 5th edition. Saunders Company, Philadelphia, 2001, pp 7–25.

    Google Scholar 

  14. Hopman AHN, Remaekers FCS, Raap AK, et al: In situ hybridization as a tool to study numeric chromosomal aberrations in solid bladder tumors. Histochemistry 89: 307–316, 1988.

    Article  PubMed  CAS  Google Scholar 

  15. Hsu SM, Raine L, Fanger H: Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29: 577–580, 1981.

    PubMed  CAS  Google Scholar 

  16. Hudelist G, Kostler W, Czervenka K, et al: Predicting the clinical course of breast cancer patients undergoing trastuzumabbased therapy: an outlook. Methods Find Exp Clin Phannacol, 26: 201–210, 2004.

    Article  CAS  Google Scholar 

  17. Leger I, Thomas M, Ronot X, Brugal G: Detection of chromosome 1 aberration by fluorescent in situ hybridization (FISH) in the human breast cancer cell line MCF-7. Anal Cell Pathol 5: 299–309, 1993.

    PubMed  CAS  Google Scholar 

  18. Jain AN, Chin K, Borresen-Dale AL, et al: Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with P53 status and patient survival. Proc Natl Acad Sci 98: 7952–7957, 2001.

    Article  PubMed  CAS  Google Scholar 

  19. Kahan E, Ibrahim, AS, Ei Najjar K, et al: Cancer patterns in the Middle East -Special report from the Middle East Cancer Society. Acta Oncol 36: 631–636, 1997.

    Article  PubMed  CAS  Google Scholar 

  20. Lalloo F: Genetics for Oncologists. Remedica, London, 2002.

    Google Scholar 

  21. Levine AJ: The tumor suppressor genes. Ann Rev Biochem 62: 623–651, 1993.

    Article  PubMed  CAS  Google Scholar 

  22. Marinho AF, Botelho M, Schmitt FC: Evaluation of numerical abnormalities of chromosome 1 and 17 in proliferative epithelial breast lesions using fluorescence in situ hybridization. Pathol Res Pract 196: 227–233, 2000.

    PubMed  CAS  Google Scholar 

  23. Mark HF, Taylor W, Afify A, et al: Stage I and II infiltrating ductal carcinoma of breast analysed for chromosome 8 copy number using fluorescent in situ hybridization. Pathobiology 65: 184–189, 1997.

    Article  PubMed  CAS  Google Scholar 

  24. Massoner A, Augustin F, Duba HC, et al: FISH cytogeuetics and prognosis in breast and non-small cell lung cancers. Cytometry 62B: 52–56, 2004.

    Article  Google Scholar 

  25. Mehdipour P, Atri M, Jafarimojarrad E, et al: Laddering through pedigrees: family history of malignancies in primary breast cancer patients. Asian Pac J Cancer Prev 4: 185–192, 2003.

    PubMed  CAS  Google Scholar 

  26. Montazeri A, Ebrahimi M, Mehrdad N, et al. Delayed prevention in breast cancer: A study in Iranian women. BMC Womens Health, 3: 4, 2003.

    Article  PubMed  Google Scholar 

  27. Nakopoulou L, Giannopoulou I, Trafalis D, et al: Evaluation of numeric alterations of chromosomes 1 and 17 by in situ hybridization in invasive breast carcinoma with clinicopathologic parameters. Appl Immunohistochem Mol Morphol 10: 20–28, 2002.

    Article  PubMed  Google Scholar 

  28. Nakopoulou L, Tsirmpa I, Giannopoulou I, et al: Aneuploidy of chromosome 20 in invasive breast cancer correlates with poor outcome. Cancer Genet Cytogenet 134: 127–132, 2002.

    Article  PubMed  CAS  Google Scholar 

  29. Persons DL, Hartmann LC, Herath JF, et al. Fluorescence in situ hybridization analysis of trisomy 12 in ovarian tumors. Am J Clin Pathol 102: 775–779, 1994.

    PubMed  CAS  Google Scholar 

  30. Persons DL, Robinson RA, Hsu P, et al. Chromosome specific aneusomy in carcinoma of the breast. Clin Cancer Res 2: 883–888, 1996.

    PubMed  CAS  Google Scholar 

  31. Roka S, Fiegl M, Zojer N, et al. Aneuploidy of chromosome 8 as detected by interphase fluorescence in situ hybridization is a recurrent finding in primary and metastatic breast cancer. Breast Cancer Res Treat 48: 125–133, 1998.

    Article  PubMed  CAS  Google Scholar 

  32. Santora LM, Mahoney MC, Lawvere S, et al. Breast cancer screening beliefs by practice location. BMC Public Health 3: 9, 2003.

    Article  PubMed  Google Scholar 

  33. Sigurdsson S, Bodvarsdottir SK, Eyfjord J: P53 abnormality and chromosomal instability in the same breast tumor cells. Cancer Genet Cytogenet 12: 150–155, 2000.

    Article  Google Scholar 

  34. Summary of Report on Cancer Incidence in Iran. Cancer and Genetics Administration, Non-Communicable Diseases Sector of Iranian Center for Prevention and Control of Diseases. Deputy of Health, Ministry of Health, Treatment and Education, Islamic Republic of Iran, 2000.

  35. Takami S, Kawasome C, Kinoshita M, et al: Chromosomal instability detected by fluorescence in situ hybridization in Japanese cancer patients. Clin Chim Acta 308: 127–131, 2001.

    Article  PubMed  CAS  Google Scholar 

  36. Truong K, Vielh P, Guilly MN, et al. Quantitative FISH analysis on interphase nuclei may improve diagnosis of DNA diploid breast cancers. Diagn Cytopathol 26: 213–216, 2002.

    Article  PubMed  Google Scholar 

  37. Union International Contre Cancer. TNM classification of International Union Against Cancer, (Eds: Harmanek P, Sobin LH). TNM Atlas, Berlin, Springer-Verlag, 1992.

    Google Scholar 

  38. World Health Organization. Histologic typing of breast tumors. In: International Histologic Classification of Tumors. (Eds: Hartman WH, Urello L, Sobin LH, Stalberg H), Geneva, WHO, 1981, pp 15–25.

    Google Scholar 

  39. Yamamoto D, Senzaki H, Nakagawa H, et al. Detection of chromosomal aneusomy by fluorescence in situ hybridization for patients with nipple discharge. Cancer 97: 690–694, 2003.

    Article  PubMed  Google Scholar 

  40. Fan Y-S: Molecular cytogenetics in medicine. In: Methods in Molecular Biology. Vol 204, Molecular Cytogenetics: Protocols and Applications, Humana Press, Totowa, NJ, 2002.

    Google Scholar 

  41. Yoshihito U, Mitsuru E, Masataka Y: Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer. Clin Cancer Res 6: 3193–3198, 2000.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Parvin Mehdipour.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Behjati, F., Atri, M., Najmabadi, H. et al. Prognostic value of chromosome 1 and 8 copy number in invasive ductal breast carcinoma among iranian women: An interphase FISH analysis. Pathol. Oncol. Res. 11, 157–163 (2005). https://doi.org/10.1007/BF02893392

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02893392

Key words

Navigation